Table 1.
ID | SCI etiology | Sex | Age at BCa diagnosis (years) | Time since SCI* (years) | Smoker at diagnosis |
---|---|---|---|---|---|
1 | Congenital MMC | F | 32 | – | No |
2 | Congenital MMC | F | 58 | – | Yes |
3 | TM | M | 83 | 40 | No |
4 | Traumatic SCI C7 | M | 71 | 51 | No |
5 | Traumatic SCI D4 | M | 48 | 27 | No |
6 | Traumatic SCI D4-D5 | M | 53 | 37 | Yes |
7 | Traumatic SCI D12 | M | 53 | 22 | Yes |
8 | Traumatic SCI L1-L2 | M | 55 | 50 | No |
9 | Traumatic SCI L1-L2 | M | 49 | 31 | Yes |
10 | Traumatic SCI D3 | M | 47 | 29 | Yes |
Cases: 10 | MMC: 2/10 (20%) | F: 2/10 (20%) | Median*: 53 | Median: 34 | No: 5/10 (50%) |
TM: 1/10 (10%) | M: 8/10 (80%) | IQR*: 48.75–59 | IQR: 28.5–42.5 | Yes: 5/10 (50%) | |
Traumatic SCI: 7/10 (70%) | Range*: 47–83 | Range: 22–51 |
BCa bladder cancer, F female, IQR inter-quartile range, M male, MMC myelomeningocele, SCI spinal cord injury, TM transverse myelitis.
*Data estimated considering only individuals with acquired spinal cord injury.